Feng Ma
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 1%
- interferon and immune responses
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Papers in
-
- RNA Research and Splicing 15
- RNA modifications and cancer 14
- Immunology 39
- interferon and immune responses 24
- Immune Response and Inflammation 14
- Immune Cell Function and Interaction 7
- Co-authors
- Xuetao Cao (10 shared papers)Xingguang Liu (8 shared papers)Jin Hou (4 shared papers)Li Lin (3 shared papers)Zhugang Wang (2 shared papers)Nan Li (4 shared papers)Pin Wang (2 shared papers)Hangping Yao (2 shared papers)
- Journals
- The Journal of Immunology (11 papers)Frontiers in Immunology (5 papers)EMBO Reports (4 papers)Oncology Reports (4 papers)Nature Immunology (3 papers)
- Partner nations
- ChinaUnited StatesCroatia
In The Last Decade
Feng Ma
112 papers receiving 5.7k citations
Feng Ma's Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 1.9k
- Immunology 2.0k
- Molecular Biology 2.5k
- Infectious Diseases 455
- Oncology 535
Countries citing papers authored by Feng Ma
This map shows the geographic impact of Feng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Ma more than expected).
Fields of papers citing papers by Feng Ma
This network shows the impact of papers produced by Feng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Ma. The network helps show where Feng Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK2 Hit paper breakdown → | 2009 | 646 |
| 2 | The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ Hit paper breakdown → | 2011 | 547 |
| 3 | 2010 | 361 | |
| 4 | 2010 | 236 | |
| 5 | 2012 | 233 | |
| 6 | 2011 | 219 | |
| 7 | 2010 | 211 | |
| 8 | 2017 | 196 | |
| 9 | 2020 | 177 | |
| 10 | 2007 | 143 | |
| 11 | 2015 | 132 | |
| 12 | 2014 | 118 | |
| 13 | 2015 | 114 | |
| 14 | 2021 | 109 | |
| 15 | 2009 | 107 | |
| 16 | 2018 | 81 | |
| 17 | 2019 | 79 | |
| 18 | 2021 | 77 | |
| 19 | 2013 | 77 | |
| 20 | 2019 | 66 |
About Feng Ma
Feng Ma is a scholar working on Molecular Biology, Immunology, Cancer Research, Surgery and Epidemiology, having authored 118 papers that have together received 5.7k indexed citations. Recurring topics across this work include interferon and immune responses (24 papers), RNA Research and Splicing (15 papers), MicroRNA in disease regulation (15 papers), Immune Response and Inflammation (14 papers), Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (14 papers), Selenium in Biological Systems (9 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Cancer Research (1.9k citations), Immunology (2.0k citations), Molecular Biology (2.5k citations), Infectious Diseases (455 citations) and Oncology (535 citations). Feng Ma has collaborated with scholars based in China, United States and Croatia. Frequent co-authors include Xuetao Cao, Xingguang Liu, Jin Hou, Li Lin, Zhugang Wang, Nan Li, Pin Wang, Hangping Yao, Huazhang An and Sheng Xu. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, EMBO Reports, Oncology Reports and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.